CDC Website CDC Website

To Join the NPIN community or

You are here

Schools

Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)

NPIN admin's picture
Grant Amount: NIDA intends to commit $1.5M in each fiscal year (FY 2015-2017) to fund 2-3 awards. Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies at the nexus of substance abuse and HIV/AIDS. This award is designed to support creative individuals who wish to pursue innovative research approaches for substance using populations with or at risk for HIV/AIDS.

Targeting Latently Infected Cells Without Reactivation (R01)

NPIN admin's picture
Grant Amount: NIAID intends to commit $2.7 million in FY2015 to fund 4-7 awards. The purpose of this Funding Opportunity Announcement (FOA) is to solicit innovative research that advances the understanding of mechanisms or approaches that could be harnessed to selectively eliminate HIV-1 latently-infected cells without depending on viral reactivation.

Advancing Structural Level Interventions Through Enhanced Understanding of Social Determinants in HIV Prevention and Care (R21)

NPIN admin's picture
Grant Amount: Unspecified. This Funding Opportunity Announcement (FOA) encourages applications that propose to understand and address social determinants associated with the prevention and treatment of HIV. This FOA describes two research endeavors that are unique and overlapping. The first is to characterize those social determinants that are most relevant to HIV prevention and treatment outcomes, particularly in their association with inequities in HIV risk or disease outcomes.

Advancing Structural Level Interventions Through Enhanced Understanding of Social Determinants in HIV Prevention and Care (R01)

NPIN admin's picture
Grant Amount: Unspecified. This Funding Opportunity Announcement (FOA) encourages applications that propose to understand and address social determinants associated with the prevention and treatment of HIV. This FOA describes two research endeavors that are unique and overlapping. The first is to characterize those social determinants that are most relevant to HIV prevention and treatment outcomes, particularly in their association with inequities in HIV risk or disease outcomes.

Strengthening Adherence to Antiretroviral-Based HIV Prevention and Treatment (R01)

NPIN admin's picture
Grant Amount: Unspecified. This Funding Opportunity Announcement (FOA) encourages research to understand and promote adherence to antiretroviral (ARV) regimens for HIV treatment and prevention. Studies addressing pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) are the foci of this FOA. The overarching emphasis is on the development of feasible interventions to improve and sustain PrEP or ART adherence which could be rapidly implemented in clinical, community, and policy environments to improve HIV treatment and prevention outcomes.

Improving Delivery of HIV Prevention and Treatment through Implementation Science and Translational Research (R01)

NPIN admin's picture
Grant Amount: Unspecified. This Funding Opportunity Announcement (FOA) encourages research designed to increase the public health impact of efficacious HIV/AIDS-related interventions for prevention and treatment. To maximize the public health impact of available interventions, significant progress is needed to advance science designed to get interventions to the men, women, and children who need them.

Improving Delivery of HIV Prevention and Treatment through Implementation Science and Translational Research (R21)

NPIN admin's picture
Grant Amount: Unspecified. This Funding Opportunity Announcement (FOA) encourages research designed to increase the public health impact of efficacious HIV/AIDS-related interventions for prevention and treatment. To maximize the public health impact of available interventions, significant progress is needed to advance science designed to get interventions to the men, women, and children who need them.

Prevention and Treatment of Substance Using Populations with or at Risk for HCV (R21)

NPIN admin's picture

Grant Amount: Unspecified. This FOA offers the opportunity to conduct exploratory clinical and basic research focused on prevention and treatment of HCV for at-risk substance using populations, including those infected with or at risk for HIV. The R21 mechanism supports investigation of novel scientific ideas or new model systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. An R21 grant application need not have extensive background material or preliminary information.

Pages

Subscribe to RSS - Schools